Effect of tiplaxtinin (PAI‐039), an orally bioavailable PAI‐1 antagonist, in a rat model of thrombosis

200862 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Thrombosis and Haemostasis

Volume 6, Issue 9, pp. 1558-1564

Field-Weighted Citation Impact: 1.94